Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 8/20 | 0.33 |
| ▸ | CNR2 | P34972 | 8/20 | 0.33 |
| ▸ | GPR18 | Q14330 | 3/20 | 0.33 |
| ▸ | GPR55 | Q9Y2T6 | 3/20 | 0.33 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.32 |
| ▸ | CES2 | O00748 | 1/20 | 0.31 |
| ▸ | ACHE | P22303 | 1/20 | 0.31 |
| ▸ | CES1 | P23141 | 1/20 | 0.31 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.30 |
| ▸ | MAPT | P10636 | 2/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | PKM | P14618 | 1/20 | 0.30 |
| ▸ | RECQL | P46063 | 1/20 | 0.30 |
| ▸ | BLM | P54132 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9008430 | 0.90 | CES2 (0.39) | CNR1CNR2GPR18GPR55CES2 | |
| SCHEMBL5643778 | 0.90 | MEN1 (0.41) | CNR1CNR2GPR18GPR55ALDH1A1 | |
| SCHEMBL10385274 | 0.89 | GPR35 (0.39) | CNR1CNR2GPR18GPR55GPR35 | |
| SCHEMBL6860826 | 0.89 | MAPT (0.42) | CNR1CNR2GPR18GPR55CES2 | |
| SCHEMBL6869888 | 0.87 | ACLY (0.33) | CES2ACHECES1GPR35ALDH1A1 | |
| SCHEMBL5651098 | 0.87 | ACLY (0.33) | CES2ACHECES1GPR35ALDH1A1 | |
| SCHEMBL11237715 | 0.83 | CES2 (0.39) | CNR1CNR2HSP90AA1CES2ACHE | |
| SCHEMBL9177992 | 0.82 | CES2 (0.39) | CNR1CNR2GPR18GPR55CES2 | |
| SCHEMBL7524129 | 0.82 | MAPT (0.42) | CNR1CNR2GPR18GPR55CES2 | |
| SCHEMBL10557291 | 0.80 | GPR35 (0.36) | GPR35 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7166659-B2 | Substituted 5-aryl-2-(2-hydroxyphenyl)-2H-benzotriazole UV absorbers, compositions stabilized therewith and process for preparation thereof | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2007-01-23 | — | — | US | disclosed |
| US-7148274-B2 | Substituted 5-aryl-2-(2-hydroxyphenyl)-2h-benzotriazole UV absorbers, compositions stabilized therewith and process for preparation thereof | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2006-12-12 | — | — | US | disclosed |
| EP-1337520-B1 | SUBSTITUTED 5-ARYL AND 5-HETEROARYL-2-(2-HYDROXYPHENYL)-2H-BENZOTRIAZOLE DERIVATIVES AS UV ABSORBERS | CIBA SC HOLDING AG (CH) | 2004-12-15 | — | — | EP | disclosed |
| US-20040192927-A1 | Substituted 5-aryl-2-(2-hydroxyphenyl)-2H-benzotriazole UV absorbers, compositions stabilized therewith and process for preparation thereof | PASTOR STEPHEN D (US) | 2004-09-30 | — | — | US | disclosed |
| US-20040157966-A1 | Substituted 5-aryl-2-(2-hydroxyphenyl)-2h-benzotriazole UV absorbers, compositions stabilized therewith and process for preparation thereof | PASTOR STEPHEN D (US) | 2004-08-12 | — | — | US | disclosed |
| US-6774238-B2 | REACTING 5-SUBSTITUTED BENZOTRIAZOLE WITH ARYLBORONIC ACID IN PRESENCE OF PALLADIUM CATALYST; DEHALOGENATION; ARYLATION | CIBA SPECIALTY CHEMICALS CORPORATION | 2004-08-10 | — | — | US | disclosed |
| US-20040092628-A1 | Substituted 5-aryl-2-(2-hydroxyphenyl)-2h-benzotriazole UV absorbers, compositions stabilized therewith and process for preparatiion thereof | PASTOR STEPHEN D (US) | 2004-05-13 | — | — | US | disclosed |
| US-6703510-B2 | MORE STABLE AND DURABLE; AUTOMOTIVE COATINGS, CANDLE WAX | CIBA SPECIALTY CHEMICALS CORPORATION | 2004-03-09 | — | — | US | disclosed |
| US-20030213164-A1 | Substituted 5-aryl-2-(2-hydroxyphenyl)-2H-benzotriazole UV absorbers, compositions stabilized therewith and process for preparation thereof | PASTOR STEPHEN D (US) | 2003-11-20 | — | — | US | disclosed |
| US-6649770-B1 | Exhibit superior hydrolytic stability, handling and storage stability as well as good resistance to extractability when present in stabilized composition | CIBA SPECIALTY CHEMICALS CORPORATION | 2003-11-18 | — | — | US | disclosed |
| EP-1337520-A1 | SUBSTITUTED 5-ARYL AND 5-HETEROARYL-2-(2-HYDROXYPHENYL)-2H-BENZOTRIAZOLE DERIVATIVES AS UV ABSORBERS | Ciba SC Holding AG (CH) | 2003-08-27 | — | — | EP | disclosed |
| WO-2002042281-A1 | SUBSTITUTED 5-ARYL AND 5-HETEROARYL-2-(2-HYDROXYPHENYL)-2H-BENZOTRIAZOLE DERIVATIVES AS UV ABSORBERS | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2002-05-30 | — | — | WO | disclosed |
| US-6387992-B1 | HEAT, OXIDATION AND LIGHT RESISTANCE | CIBA SPECIALTY CHEMICALS CORPORATION | 2002-05-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040192927-A1 | Substituted 5-aryl-2-(2-hydroxyphenyl)-2H-benzotriazole UV absorbers, compositions stabilized therewith and process for preparation thereof | EBPL, DDT, AHR | CNR1 2333/4885CNR2 1960/4885GPR18 2897/4885 |
| US-20030213164-A1 | Substituted 5-aryl-2-(2-hydroxyphenyl)-2H-benzotriazole UV absorbers, compositions stabilized therewith and process for preparation thereof | EBPL, DDT, AHR | CNR1 2333/4885CNR2 1960/4885GPR18 2897/4885 |
| US-20040092628-A1 | Substituted 5-aryl-2-(2-hydroxyphenyl)-2h-benzotriazole UV absorbers, compositions stabilized therewith and process for preparatiion thereof | AHR, PAH, CCNL2 | CNR1 1751/4885CNR2 1562/4885GPR18 2705/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.